EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Randomised, controlled, feasibility trial comparing vasopressor infusion administered via peripheral cannula versus central venous catheter for critically ill adults: A study protocol

Stacey Watts iD, Yogesh Apte iD, Thomas Holland, April Hatt iD, Alison Craswell, Frances Lin iD, Alexis Tabah, Robert Ware, Joshua Byrnes, Christopher Anstey, Gerben Keijzers, Mahesh Ramanan iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0295347 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Stacey Watts und 11 weiteren Autor:innen. Beteiligte Einrichtung: Caboolture Hospital, Caboolture, Australia. Hauptthemen laut MEDLINE: Catheterization, Peripheral, Central Venous Catheters, Critical Illness, Feasibility Studies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Prince Charles Hospital Foundation, Emergency Medicine Foundation, University of Queensland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

When clinicians need to administer a vasopressor infusion, they are faced with the choice of administration via either peripheral intravenous catheter (PIVC) or central venous catheter (CVC). Vasopressor infusions have traditionally been administered via central venous catheters (CVC) rather than Peripheral Intra Venous Catheters (PIVC), primarily due to concerns of extravasation and resultant tissue injury. This practice is not guided by contemporary randomised controlled trial (RCT) evidence. Observational data suggests safety of vasopressor infusion via PIVC. To address this evidence gap, we have designed the “Vasopressors Infused via Peripheral or Central Access” (VIPCA) RCT.

Methods

The VIPCA trial is a single-centre, feasibility, parallel-group RCT. Eligible critically ill patients requiring a vasopressor infusion will be identified by emergency department (ED) or intensive care unit (ICU) staff and randomised to receive vasopressor infusion via either PIVC or CVC. Primary outcome is feasibility, a composite of recruitment rate, proportion of eligible patients randomised, protocol fidelity, retention and missing data. Primary clinical outcome is days alive and out of hospital up to day-30. Secondary outcomes will include safety and other clinical outcomes, and process and cost measures. Specific aspects of safety related to vasopressor infusions such as extravasation, leakage, device failure, tissue injury and infection will be assessed.

Discussion

VIPCA is a feasibility RCT whose outcomes will inform the feasibility and design of a multicentre Phase-3 trial comparing routes of vasopressor delivery. The exploratory economic analysis will provide input data for the full health economic analysis which will accompany any future Phase-3 RCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Catheterization, PeripheralCentral Venous CathetersCritical IllnessFeasibility StudiesVasoconstrictor AgentsAdultFemaleHumansMaleCatheterization, Central VenousInfusions, IntravenousIntensive Care UnitsRandomized Controlled Trials as Topic

Substanzen

Vasoconstrictor Agents

Autor:innen und Institutionen

  • Caboolture Hospital, Caboolture, Australia.
  • James Mayne Academy of Critical Care, The University of Queensland, Brisbane, Australia.
  • School of Health, University of the Sunshine Coast, Sippy Downs, Australia.
  • Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia.
  • Sunshine Coast Health Institute, School of Health, University of the Sunshine Coast, Sippy Downs, Australia.
  • Intensive Care Unit, Redcliffe Hospital, Brisbane, Australia.

ORCID-Profile: Stacey Watts, Yogesh Apte, April Hatt, Frances Lin, Mahesh Ramanan

Förderung

  • The Prince Charles Hospital Foundation
  • Emergency Medicine Foundation
  • University of Queensland

Zitieren

APA

Watts, S., Apte, Y., Holland, T., Hatt, A., Craswell, A., Lin, F., Tabah, A., Ware, R., Byrnes, J., Anstey, C., Keijzers, G., & Ramanan, M. (2024). Randomised, controlled, feasibility trial comparing vasopressor infusion administered via peripheral cannula versus central venous catheter for critically ill adults: A study protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0295347

Vancouver

Watts S, Apte Y, Holland T, Hatt A, Craswell A, Lin F, et al. Randomised, controlled, feasibility trial comparing vasopressor infusion administered via peripheral cannula versus central venous catheter for critically ill adults: A study protocol. PLOS ONE. 2024. doi:10.1371/journal.pone.0295347

BibTeX
@article{Watts2024,
  author = {Watts, Stacey and Apte, Yogesh and Holland, Thomas and Hatt, April and Craswell, Alison and Lin, Frances and Tabah, Alexis and Ware, Robert and Byrnes, Joshua and Anstey, Christopher and Keijzers, Gerben and Ramanan, Mahesh},
  title = {Randomised, controlled, feasibility trial comparing vasopressor infusion administered via peripheral cannula versus central venous catheter for critically ill adults: A study protocol},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0295347}
}
Kostenlos starten →